My INR is 1.8; I am taking warfarin 5 mg on Monday, Wednesday, and Friday and 4 mg on the other days. What change should I make to the dosing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Warfarin Dose Adjustment for INR 1.8

Increase your total weekly warfarin dose by 5-15% and recheck your INR in 1-2 weeks. Given your current regimen (5 mg on M/W/F and 4 mg on other days = 29 mg/week), this translates to adding approximately 1.5-4.5 mg to your weekly total.

Recommended Dosing Strategy

Practical Adjustment Options:

Option 1 (10% increase): Add 3 mg/week

  • Take 5 mg on Monday, Wednesday, Friday, Saturday
  • Take 4 mg on Tuesday, Thursday, Sunday
  • New weekly total: 32 mg

Option 2 (Conservative 5% increase): Add 1.5 mg/week

  • Take 5 mg on Monday, Wednesday, Friday, Sunday
  • Take 4 mg on Tuesday, Thursday, Saturday
  • New weekly total: 30.5 mg

Rationale

Your INR of 1.8 is slightly below the typical therapeutic range of 2.0-3.0 1. The 2012 ACCP guidelines specifically address this scenario, noting that for a single out-of-range INR of 0.5 below therapeutic, you could either continue the current dose or make a modest adjustment 1.

However, the evidence shows minimal difference between dose adjustment versus watchful waiting for slightly out-of-range INRs. A 2010 randomized trial found that single-dose corrections resulted in therapeutic INRs in 60% of patients versus 56% with no change (not statistically significant) 2. A 2022 study similarly showed only a 1.1% absolute difference (58.9% vs 60.0%) between strategies 3.

Why Adjust Rather Than Wait?

While guidelines suggest either approach is reasonable, making a small weekly dose increase is prudent because:

  • An INR of 1.8 represents subtherapeutic anticoagulation, increasing thrombotic risk
  • The evidence supporting "watchful waiting" primarily applies to INRs of 1.5-1.99, and your value is at the lower end 1
  • Studies show no increased bleeding risk with modest dose adjustments 2
  • A 5-15% weekly dose change is standard practice for steady-state adjustments 4

Critical Follow-Up

  • Recheck INR in 1-2 weeks 1
  • Do not make further adjustments until you see the response to this change
  • If INR remains below 2.0 at follow-up, consider an additional 5-10% weekly increase

Important Caveats

Do NOT bridge with heparin for a single subtherapeutic INR unless you have a mechanical heart valve or very high thrombotic risk 1. Studies show thromboembolic event rates of only 0.3-0.4% with single low INRs, even without bridging 1.

Avoid these common pitfalls:

  • Don't double a single dose to "catch up" - adjust the weekly total instead
  • Don't make changes more frequently than weekly intervals
  • Maintain consistent vitamin K intake in your diet
  • Report any new medications, as drug interactions are a leading cause of INR fluctuations 5

Consider underlying causes: Review recent dietary changes (especially green leafy vegetables), new medications, missed doses, or illness that might explain the low INR before making adjustments.

Related Questions

A patient taking warfarin (Coumadin) 1 mg daily has an INR of 1.2; is a dose adjustment needed?
In a patient taking warfarin 5 mg daily with a current INR of 1.9 (target therapeutic range 2.0–3.0) and a previous INR of 2.0 last month, should the dose be adjusted or continued unchanged?
What is the appropriate management for a female patient with an INR of 1.8 who missed a dose of Coumadin (warfarin), given the target INR range of 2–3?
What should I do with an INR of 3.3 while alternating warfarin (warfarin) doses of 2.5 mg and 3 mg?
A patient taking warfarin 5 mg on Sunday, Monday, Wednesday, Friday, and Saturday and 2.5 mg on Tuesday and Thursday has an international normalized ratio (INR) of 1.5 (previous INR 2). How should the warfarin dose be adjusted?
How should a 35-year-old woman with elevated thyroid peroxidase antibodies (503 IU/mL) and normal thyroid‑stimulating hormone (TSH), free thyroxine (free T4), and total triiodothyronine (total T3) be managed?
What is the next step in management for a patient with a white blood cell count of 4–4.4 ×10⁹/L persisting for the past two years?
Why is spironolactone used to treat hypertension in patients with primary hyperaldosteronism?
How should I conduct a comprehensive well‑child visit for a 4‑year‑old child, including immunizations, growth assessment, physical examination, developmental screening, vision and hearing tests, nutrition and safety counseling, and appropriate referrals?
In a patient with type 2 diabetes and chronic kidney disease (eGFR ≥ 15 mL/min/1.73 m²), which GLP‑1 receptor agonist is recommended and what dosing regimen should be used?
In a patient who works as a driver with 10‑hour daily shifts, how many days after radical prostatectomy versus external beam radiotherapy can he safely return to full work duties?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.